JPRN-jRCT2080221195未知1 期
Phase 1 Study of Ipilimumab (BMS-734016) in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer
Bristol-Myers K.K.0 个研究点目标入组 15 人开始时间: 2010年8月11日最近更新:
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Histologically or cytologically documented NSCLC who present with stage IIIB without indications for definitive radiotherapy or stage IV or recurrent
- •- No prior chemotherapy, hormonal therapy, immunotherapy and targeted therapy containing regimens for the treatment of NSCLC
排除标准
- •- Symptomatic central nervous system (CNS) metastasis, or active CNS metastasis requiring medication.
- •- Malignant body cavity fluid (e.g. pleural effusion, cardiac effusion, ascites) that is recurrent despite appropriate supportive care.
- •- Autoimmune disease: subjects with a documented history of severe autoimmune or immune mediated symptomatic disease that required prolonged (more than 2 months) systemic immunosuppressant treatment
研究者
相似试验
进行中（未招募）
不适用
A Phase II Study of the Combination of Ipilimumab and Fotemustine in Patients with Unresectable Locally Advanced or Metastatic Malignant Melanoma - NIBIT-M1EUCTR2010-019356-50-ITIBIT (NETWORK ITALIANO PER LA BIO-IMMUNOTERAPIA DEI TUMORI)
已完成
1 期
A Phase Ib/II Trial of Ipilimumab-Nivolumab-Denosumab and Nivolumab-Denosumab in Patients with Unresectable Stage III and IV MelanomaMelanomaACTRN12617000772347Peter MacCallum Cancer Centre52
招募中
2 期
A phase II study of ipilimumab, nivolumab, and radiotherapy for advanced NSCLCJPRN-jRCTs021220003Miyauchi Eisaku40
进行中（未招募）
1 期
A Phase II trial of the addition of Ipilimumab to Carboplatin and Etoposide chemotherapy for the treatment of Extensive Stage Small Cell Lung CancerExtensive stage small cell lung cancerEUCTR2010-021863-34-GBniversity Hospital Southampton NHS Foundation Trust40
已完成
1 期
Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung CancerNon-Small Cell Lung CancerNCT01165216Bristol-Myers Squibb15